Contact Us

Use the form on the right to contact us.

You can edit the text in this area, and change where the contact form on the right submits to, by entering edit mode using the modes on the bottom right. 

54 West 40th Street
New York, NY, 10018
United States

908-247-8443

CRISSCROSS Intimates - Luxury Intimate Apparel for Women and Men.  Post-surgical undergarments for Breast Cancer Survivors, Reconstructive Surgery, Augmentative Surgery, Gynecosmastia and other Breast Surgeries. Comfortable, chic compression Bras for any stage or phase during your recovery, plus Panties, Leggings, Pouch, Men's and other accessories and products.

Matching Panties,  Leggings, Accessories, Men's Compression Vests and products of Inspiration.

CRISSCROSS - your Breast kept secret!

BREAST FACTS-backup

Breast Facts

The Facts: Women (2017) - About 1 in 8 U.S. women (about 12%) will develop invasive breast cancer over the course of her lifetime.  Every 2 minutes a woman is diagnosed with breast cancer; every 13 minutes a woman in the U.S. will die of this disease.

The Facts: Men (2017) - About 2,470 new cases of invasive breast cancer are expected to be diagnosed in men in 2017. Breast cancer risk is much lower in men than in women. A man’s lifetime risk of breast cancer is about 1 in 1,000 (about 1%).

The Facts: In the United States (2017):

  • In 2017, an estimated 255,180 new cases of invasive breast cancer are expected to be diagnosed in women in the U.S. along with 63,410 new cases of non-invasive (in situ) breast cancer.

  • More U.S. Women are Choosing Mastectomy Over Lumpectomy for Early Stage Breast Cancer. 35% vs 65% choose mastectomy over lumpectomy and that number has been increasing according to the U.S. National Institute of Health released a statement in 1990 saying that lumpectomy plus radiation was preferred over mastectomy to treat early-stage breast cancer. Still, some women who’ve been diagnosed with early-stage breast cancer in one breast choose to have that breast and the other healthy breast removed. Removing the other healthy breast is called contralateral prophylactic mastectomy.  

  • The study published on Nov. 19, 2014 by JAMA Surgery “Nationwide Trends in Mastectomy for Early-Stage Breast Cancer." Researchers looked at medical records of more than 1.2 million women diagnosed with early-stage breast cancer in one breast and treated at centers across the U.S. from 1998 to 2011. The records are part of the National Cancer Data Base, a nationwide database created by the American Cancer Society and the American College of Surgeons Commission on Cancer. 

  • Breast cancer incidence rates in the U.S. began decreasing in the year 2000, after increasing for the previous two decades. They dropped by 7% from 2002 to 2003 alone. One theory is that this decrease was partially due to the reduced use of hormone replacement therapy (HRT) by women after the results of a large study called the Women’s Health Initiative were published in 2002. These results suggested a connection between HRT and increased breast cancer risk.
  • About 40,610 women in the U.S. are expected to die in 2017 from breast cancer, though death rates have been decreasing since 1989. Women under 50 have experienced larger decreases. These decreases are thought to be the result of treatment advances, earlier detection through screening, and increased awareness.

For Women in the U.S.: breast cancer death rates are higher than those for any other cancer, besides lung cancer. Besides skin cancer, breast cancer is the most commonly diagnosed cancer among American women. In 2016, it's estimated that just under 30% of newly diagnosed cancers in women will be breast cancers.

  • In women under 45, breast cancer is more common in African-American women than white women. Overall, African-American women are more likely to die of breast cancer. For Asian, Hispanic, and Native-American women, the risk of developing and dying from breast cancer is lower.
  • In 2016, there were more than 2.8 million women with a history of breast cancer in the U.S. This included women being treated and women who finished treatment.
  • A woman’s risk of breast cancer nearly doubles if she has a first-degree relative (mother, sister, daughter) who has been diagnosed with breast cancer. Less than 15% of women who get breast cancer have a family member diagnosed with it.
  • About 5-10% of breast cancers can be linked to gene mutations (abnormal changes) inherited from one’s mother or father. Mutations of the BRCA1 and BRCA2 genes are the most common. On average, women with a BRCA1 mutation have a 55-65% lifetime risk of developing breast cancer. For women with a BRCA2 mutation, the risk is 45%. Breast cancer that is positive for the BRCA1 or BRCA2 mutations tends to develop more often in younger women. An increased ovarian cancer risk is also associated with these genetic mutations. In men, BRCA2 mutations are associated with a lifetime breast cancer risk of about 6.8%; BRCA1 mutations are a less frequent cause of breast cancer in men.
  • About 85% of breast cancers occur in women who have no family history of breast cancer. These occur due to genetic mutations that happen as a result of the aging process and life in general, rather than inherited mutations.
  • The most significant risk factors for breast cancer are gender (being a woman) and age (growing older).

For Men in the U.S.: Rates of breast cancer incidence (new cases) and mortality (death) are much lower among men than among women.  The fact is men do have breast tissue. Although rare, they can get breast cancer. In the U.S., more than 2,000 cases of breast cancer are diagnosed in men and more than 400 men will die from breast cancer each year. Men at any age may develop breast cancer, but it is usually detected (found) in men between 60 and 70 years of age. Male breast cancer makes up less than 1% of all cases of breast cancer. The following types of breast cancer are found in men:

  • Infiltrating ductal carcinoma: Cancer that has spread beyond the cells lining ducts in the breast. Most men with breast cancer have this type of cancer.

  • Ductal carcinoma in situ: Abnormal cells that are found in the lining of a duct; also called intra-ductal carcinoma.

  • Inflammatory breast cancer: A type of cancer in which the breast looks red and swollen and feels warm.

  • Paget disease of the nipple: A tumor that has grown from ducts beneath the nipple onto the surface of the nipple.

Lobular carcinoma in situ (abnormal cells found in one of the lobes or sections of the breast), which sometimes occurs in women, has not been seen in men].

If you are a man, who has recently been diagnosed with Breast Cancer or are in need of surgical treatment or may be in need of breast reduction surgery (Gynecomastia), there are new undergarments available -- the Joe & Arrow Men’s Vests will provide post-op compression and hide under your dress shirt or casual t-shirts.  One style has is strapless and the other is over the shoulder – both providing the same form of compression and will hold a removable drains on both sides if needed. Pouches are available for purchase.  Feel Confident, Look Handsome!

The Facts: Around The World (2016):

  • Breast cancer is the most frequently diagnosed cancer in the world and the leading cause of cancer death in women, with an estimated 1.7 million new cases recorded in 2012.

  • Every 60 seconds, somewhere in the world, someone dies from breast cancer.

  • At the current rate, 13 million breast cancer deaths around the world will occur in the next 25 years.

Incidence (new cases) rates Overall, new cases of breast cancer is about the same for black and white women. However, African-American women under age 45 have a higher incidence of breast cancer than white women. Hispanic/Latina women are more likely than white women to be diagnosed with late stage breast cancers. They also tend to have larger tumors than white women. Breast cancer incidence is lower among Asian/Pacific Islander women than for white and black women. New Asian-American immigrants also have lower rates of breast cancer than those who have lived in the U.S. for many years. Yet, for those born in the U.S., the risk is about the same as that of white women.

                   January 10, 2017 at 11:00 AM                                                                                 Source: U.S. Breast Cancer Statistics.org

 

The CRISSCROSS Facts: Each garment was designed thinking about the length of time these undergarments must be worn during your recovery process. Once the fluids deplete, and your drains come out, the CRISSCROSS line will offer additional solutions to carry you through your entire recovery and days ahead from Day 1 - 180+.  Today, we are introducing the initial Phase of the line (Days 1 - 90) and many other garments will follow.   An assortment of trending colors and styles are available to ensure you feel good about yourself at home or in the workplace.  That's what I had in mind when designing the brand. I hope you will enjoy your new CRISSCROSS product.

For more information about warning signs and prevention for both women and men, I invite you to follow Breast Cancer National Research Statistics and Susan G. Komen.  As a former Board of Trustee of SGK/North Jersey, I continue to support local affiliates and their national organization.  They are a great resource, trusted friend and neighbor to me as a Survivor and to all Survivors in our communities - don't be afraid to call upon your local breast friends.

Lookbook →